SFX by Ex Libris Inc.

Title:	Analyses of the Molecular Mechanism of Adriamycin-Induced Cardiotoxicity
Source:	Free Radical Biology and Medicine [0891-5849] Gille, Lars yr:1997

Basic

Full text

Full text available via EZB-NALI5-00465 Elsevier Archive NL

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Geisberg, Carrie A. "Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage." Current Hypertension Reports 12.6 (2010): 404-410.
description	2.	Doroshow, James H. "Effect of anthracycline antibiotics on oxygen radical formation in rat heart." Cancer research 43.2 (1983): 460-72.
description	3.	Pouna, P. "Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention." British journal of pharmacology 117.7 (1996): 1593-1599.
description	4.	Dodos, F. "Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults." Clinical research in cardiology 97.5 (2008): 318-326.
description	5.	Schwartz, R. "Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group." Pediatrics 89.5 Pt 1 (1992): 942-9.
description	6.	Tirosh, R. "Role of iron in the potentiation of anthracycline cardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction." The Journal of laboratory and clinical medicine 127.3 (1996): 272-8.
description	7.	Hoffmann, M. "A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma." Cancer research 70.6 (2010): 2328-2338.
description	8.	Siveski-Iliskovic, N. "Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats." Circulation 89.6 (1994): 2829-35.
description	9.	Spencer, Damian M S M. "DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair." Mutation research 638.1-2 (2008): 110-21.
description	10.	STEWART, J. "RADIATION-INJURY TO THE HEART." International journal of radiation oncology, biology, physics 31.5 (1995): 1205-1211.
description	11.	Chen, X. "Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy." Cardiovascular drugs and therapy 21.5 (2007): 367-374.
description	12.	Doroshow, J.H. H. "Anthracycline antibiotic-stimulated superoxide, hydrogen peroxide, and hydroxyl radical production by NADH dehydrogenase." Cancer research 43.10 (1983): 4543-4551.
description	13.	Hopwood, David A. "Genetic Contributions to Understanding Polyketide Synthases." Chemical reviews 97.7 (1997): 2465-2498.
description	14.	Lefrak, E A A. "A clinicopathologic analysis of adriamycin cardiotoxicity." Cancer 32.2 (1973): 302-14.
description	15.	Kremer, Leontine C M C. "Anthracycline cardiotoxicity in children." The New England journal of medicine 351.2 (2004): 120-1.
description	16.	Staunton, J. "Polyketide biosynthesis: a millennium review." Natural product reports 18.4 (2001): 380-416.
description	17.	Ho, E. "Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study." Heart 96.9 (2010): 701-707.
description	18.	Halsted, W S S. "I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894." Annals of surgery 20.5 (1894): 497-555.
description	19.	Stoddard, M F F. "Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans." Journal of the American College of Cardiology 20.1 (1992): 62-9.
description	20.	Shen, B. "Polyketide biosynthesis beyond the type I, II and III polyketide synthase paradigms." Current opinion in chemical biology 7.2 (2003): 285-95.